NCIMB Secures £1.7M Investment for Growth and Expansion

Aberdeen-based NCIMB Limited, a leader in microbiology services, has successfully raised £1.7 million from the Investment Fund for Scotland, managed by the Scottish National Investment Bank and Maven Capital Partners. This funding marks a significant step in NCIMB’s plans to enhance its core microbiology and strain licencing services, emphasising its key role in multiple industries including pharmaceuticals and biotechnology. 

NCIMB owns the UK’s largest industrial, food, and marine bacterial culture collection, providing microbial identification, testing, and storage. The company’s services are crucial for clients across pharmaceuticals, biotechnology, food & drink, energy, and environmental sectors. The recent funding will be dedicated to expanding NCIMB’s service offerings, enabling the selection and development of bacterial strains tailored for specific customer applications. Maven Capital Partners, having identified NCIMB at an IFS Roadshow in Aberdeen, sees this as a strategic investment, banking on NCIMB’s globally recognised expertise and capacity to meet the growing demand for Contract Research Organisations (CRO).